Item 2.01. Completion of Acquisition or Disposition of Assets

This Current Report on Form 8-K/A amends and supplements Items 9.01(a) and 9.01(b) of the Current Report on Form 8-K filed by NightHawk Biosciences, Inc. (the "Company") (formerly Heat Biologics, Inc.) with the Securities and Exchange Commission on April 20, 2022 (the "Initial Form 8-K") to include audited financial statements for the years ended December 2021 and 2020 for Elusys Therapeutics, Inc. ("Elusys") and unaudited pro forma condensed combined financial information of the Company reflecting ownership of Elusys as of and for the year ended December 31, 2021, which were permitted pursuant to Item 9.01 of Form 8-K to be excluded from the Initial Form 8-K and filed by amendment to the Initial Form 8-K no later than 71 days after the date the Initial Form 8-K was required to be filed.




Item 9.01.  Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired

Elusys' audited financial statements as of and for the year ended December 31, 2021 and as of and for the years ended December 31, 2020 and 2019 are filed herewith as Exhibits 99.1 and 99.2 and incorporated by reference in this Item 9.01(a).

(b) Unaudited Pro Forma Financial Information

The pro forma condensed combined financial information of the Company required by Item 9.01(b) of Form 8-K is filed herewith as Exhibit 99.3 and incorporated by reference in this Item 9.01(b).





(d) Exhibits.

The following exhibits are filed with this Amendment No. 1 to Current Report on Form 8-K.





Exhibit
Number    Description
 23.1       Consent of Cherry Bekaert LLP, independent auditor
 23.2       Consent of EisnerAmper LLP independent auditor
 99.1       Elusys Therapeutics, Inc. audited financial statements as of and for
          the year ended December 31, 2021
 99.2       Elusys Therapeutics, Inc. audited financial statements as of and for
          the years ended December 31, 2020 and 2019
 99.3       NightHawk Biosciences, Inc. Unaudited Pro Forma Condensed Combined
          Financial Statements as of and for the year ended December 31, 2021
  104     Cover Page Interactive Data File (the cover page XBRL tags are embedded
          within the inline XBRL document)

© Edgar Online, source Glimpses